Cargando…
Correction: Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study
Autores principales: | Chiu, Chih-Chiang, Lu, Mong-Liang, Huang, Ming-Chyi, Chen, Po-Yu, Lin, Yen-Kuang, Lin, Shih-Ku, Chen, Chun-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815597/ https://www.ncbi.nlm.nih.gov/pubmed/29451914 http://dx.doi.org/10.1371/journal.pone.0193315 |
Ejemplares similares
-
Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study
por: Chiu, Chih-Chiang, et al.
Publicado: (2016) -
Associations of Genetic Variants of Methylenetetrahydrofolate Reductase and Serum Folate Levels with Metabolic Parameters in Patients with Schizophrenia
por: Chen, Chun-Hsin, et al.
Publicado: (2021) -
Interaction of clozapine with metformin in a schizophrenia rat model
por: Horvath, G., et al.
Publicado: (2021) -
Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics
por: Chen, Po-Yu, et al.
Publicado: (2018) -
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)